NASDAQ:TNGX

Tango Therapeutics (TNGX) News Today

$7.81

+3.98 (+103.92%)

(As of 08/9/2023 ET)

Compare

Today's Range: $5.00
▼
$9.39
50-Day Range: $2.67
▼
$7.81
52-Week Range: $2.47
▼
$9.39

Volume: 74.84 million shs
Average Volume: 694,361 shs
Market Capitalization: $690.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.00

Source

Source	Headline
	Why Is Tango Therapeutics (TNGX) Stock Up 117% Today? investorplace.com - August 9 at 12:30 PM
	marketbeat.com - August 9 at 10:05 AM
	marketbeat.com - August 9 at 9:47 AM
	Tango Therapeutics (NASDAQ:TNGX) Announces Quarterly Earnings Results americanbankingnews.com - August 9 at 9:44 AM
	HC Wainwright & Co. Reiterates Tango Therapeutics (TNGX) Buy Recommendation msn.com - August 8 at 9:17 PM
	Barclays Releases a Buy Rating on Tango Therapeutics (TNGX) markets.businessinsider.com - August 8 at 11:16 AM
	H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX) markets.businessinsider.com - August 8 at 11:16 AM
	Tango Therapeutics, Inc.: Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights finanznachrichten.de - August 7 at 9:50 AM
	Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates msn.com - August 7 at 9:50 AM
	Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights finance.yahoo.com - August 7 at 9:50 AM
	Tango Therapeutics: Partial Phase 1 Data Has Not Helped seekingalpha.com - July 26 at 7:29 PM
	Tango Therapeutics Announces First Patient Dosed in TNG260 Phase 1/2 Trial in Patients With STK11-Mutant Cancers finance.yahoo.com - July 24 at 8:41 AM
	Tango Therapeutics Announces First Patient Dosed in TNG462 Phase 1/2 Trial in Patients With MTAP-deleted Solid Tumors finance.yahoo.com - July 10 at 9:48 AM
	Tango Therapeutics (TNGX) Gets a Buy from Barclays markets.businessinsider.com - June 26 at 5:20 AM
	Avoro Capital Advisors LLC Raises Stock Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) marketbeat.com - June 14 at 5:27 AM
	Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely? finance.yahoo.com - June 1 at 1:54 PM
	Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Swiss National Bank marketbeat.com - June 1 at 5:12 AM
	Wedbush Reiterates Tango Therapeutics (TNGX) Outperform Recommendation msn.com - May 12 at 2:00 PM
	Q3 2023 Earnings Forecast for Tango Therapeutics, Inc. Issued By SVB Leerink (NASDAQ:TNGX) marketbeat.com - May 12 at 8:52 AM
	Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Misses Revenue Estimates finance.yahoo.com - May 9 at 5:11 PM
	Tango Therapeutics: Q1 Earnings Insights msn.com - May 9 at 5:11 PM
	Goldman Sachs Sticks to Its Buy Rating for Tango Therapeutics (TNGX) markets.businessinsider.com - May 9 at 5:11 PM
	Tango Therapeutics, Inc.: Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights finanznachrichten.de - May 9 at 8:35 AM
	Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights finance.yahoo.com - May 9 at 8:35 AM
	Allspring Global Investments Holdings LLC Has $208,000 Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) marketbeat.com - April 20 at 4:19 AM
	Tango Therapeutics Presents Preclinical Data on Precision Oncology Programs at the American Association of Cancer Research 2023 Annual Meeting finance.yahoo.com - April 18 at 6:53 PM
	Tango Therapeutics Announces FDA Clearance of Investigational New tmcnet.com - April 3 at 9:49 AM
	Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG260, a First-in-Class CoREST Inhibitor for the Treatment of STK11-Mutant Cancers finance.yahoo.com - April 3 at 9:49 AM
	Tango Therapeutics GAAP EPS of -$0.33 beats by $0.03, revenue of $6.41M beats by $0.09M msn.com - March 28 at 11:45 PM
	Looking Into Tango Therapeutics's Return On Capital Employed msn.com - March 28 at 1:44 PM
	HC Wainwright Increases Tango Therapeutics (NASDAQ:TNGX) Price Target to $11.00 marketbeat.com - March 28 at 7:58 AM
	Tango Therapeutics (TNGX) Receives a Buy from H.C. Wainwright markets.businessinsider.com - March 28 at 7:45 AM
	Tango Therapeutics, Inc.: Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights finanznachrichten.de - March 27 at 11:44 AM
	Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates finance.yahoo.com - March 27 at 11:44 AM
	Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights finance.yahoo.com - March 27 at 11:44 AM
	Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights finance.yahoo.com - March 27 at 11:44 AM
	TNGX Tango Therapeutics, Inc. seekingalpha.com - March 17 at 9:19 PM
	Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Programs at the American Association of Cancer Research 2023 Annual Meeting finance.yahoo.com - March 14 at 10:48 PM
	Tango Therapeutics Announces Limited Exposure to Silicon Valley Bank finance.yahoo.com - March 11 at 3:24 AM
	Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - March 6 at 10:39 AM
	Strong week for Tango Therapeutics (NASDAQ:TNGX) shareholders doesn't alleviate pain of one-year loss finance.yahoo.com - March 5 at 2:02 PM
	Tango Therapeutics Announces Appointment of Adam Crystal, M.D., Ph.D. as President of Research and Development finance.yahoo.com - February 28 at 7:06 AM
	Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Sold by Barclays PLC marketbeat.com - February 14 at 4:24 AM
	Allspring Global Investments Holdings LLC Purchases New Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) marketbeat.com - January 26 at 4:28 AM
	Tango's IND For TNG462 Gets FDA Clearance; TNG908 Granted Orphan Drug Designation markets.businessinsider.com - January 25 at 10:05 AM
	Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG462; Provides Additional Business Updates finance.yahoo.com - January 25 at 10:05 AM
	We're Not Very Worried About Tango Therapeutics' (NASDAQ:TNGX) Cash Burn Rate nz.finance.yahoo.com - December 23 at 9:28 AM
	Tango Therapeutics's Return on Invested Capital Insights msn.com - December 20 at 3:08 PM
	HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors finance.yahoo.com - December 15 at 8:40 AM
	Wedbush Increases Tango Therapeutics (NASDAQ:TNGX) Price Target to $21.00 marketbeat.com - November 16 at 3:13 PM

Get Tango Therapeutics News Delivered to You Automatically

TNGX Media Mentions By Week

TNGX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNGX
News Sentiment
▼
0.38

0.42
▲
Average
Medical
News Sentiment

TNGX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNGX Articles
This Week
▼
12

1
▲
TNGX Articles
Average Week

Get Tango Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:TNGX) was last updated on 8/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tango Therapeutics (TNGX) News Today

TNGX Media Mentions By Week

TNGX Media Sentiment

TNGX News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info